TriRx Speke - Administration

TriRx Speke, a Liverpool-based pharmaceutical company for the veterinary industry, entered administration on 12 September, citing a situation with its core customer as the primary reason behind the appointment.

The company, which employs 280 staff, worked with stakeholders to resolve the situation and safeguard the future of the business. 

Oliver Wright, Christopher Bennett and Matthew Callaghan of FTI were appointed joint administrators, and said that their primary focus is to work with employees, the core customer, subcontractors and suppliers to continue production over the next few weeks, while pursuing an accelerated sale of the business. 

Callodine Commercial Finance has a registered charge against the company.